Education Lab/CME

wetAMD
CME

Reducing Treatment Burden in Neovascular Age-related Macular Degeneration: What’s Now? What’s Next?

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Expiration Date: 9/14/2019
Credit Type(s): CME | Credit: 1.5

Neovascular, or “wet” age-related macular degeneration (nAMD) imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have been…

go to activity»
J755
CME

Revolutionizing the Treatment of Neovascular Retinal Disease by Targeting the Angiopoietin-Tie Pathway

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 8/21/2019
Credit Type(s): CME | Credit: 0.75

The treatment of neovascular retinal disease has been revolutionized by the utilization of intravitreal anti-vascular endothelial growth factor (VEGF) therapy. However…

go to activity»
IED
CME

Inflammatory Eye Disorders: Diagnosis, Treatment, and Referral

This activity is supported by an educational grant from AbbVie, Inc.

Expiration Date: 7/23/2019
Credit Type(s): CME | Credit: 1

Underlying conditions leading to ocular tissue inflammation can be challenging to diagnose, treat, and effectively manage. In addition to the potential for vision loss…

go to activity»
Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment
CME

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 5/25/2019
Credit Type(s): CME | Credit: 1.25

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Ocular Surface
CME

Preserving the Ocular Surface: Practice Pearls Part 3

This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.

Expiration Date: 4/23/2019
Credit Type(s): CME | Credit: 0.5

Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with ocular surface disease are underdiagnosed in the…

go to activity»
Macular Degeneration CME
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/25/2019
Credit Type(s): CME | Credit: 1.25

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it…

go to activity»
J504
CME

Rapid Response from DC: Management of Miosis and Postsurgical Pain in Cataract Surgery

This activity is supported by an educational grant from Omeros Corporation.

Expiration Date: 9/3/2019
Credit Type(s): CME | Credit: 0.75

Interoperative miosis increases the risk of complications such as posterior capsule rupture, vitreous loss, corneal edema, and cystoid macular edema during cataract…

go to activity»
J526
CME

New Insights on the Management of Miosis and Postsurgical Pain in Cataract Surgery

This activity is supported by an educational grant from Omeros Corporation.

Expiration Date: 7/24/2019
Credit Type(s): CME | Credit: 0.5

Intraoperative miosis and postoperative inflammation and pain are common problems that ophthalmologists encounter when performing cataract surgery. Although…

go to activity»
DR
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 6/10/2019
Credit Type(s): CME | Credit: 1.25

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Proliferative and Non-proliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment
CME

Proliferative and Nonproliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/26/2019
Credit Type(s): CME | Credit: 0.5

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
J176
CME

Noninfectious Uveitis: Moving Beyond Convention for Long-Term Management

This activity is supported by educational grants from AbbVie, Inc.; Mallinckrodt Pharmaceuticals; and Santen Inc.

Expiration Date: 4/16/2019
Credit Type(s): CME | Credit: 0.75

Noninfectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, a timely diagnosis must be provided, and the…

go to activity»
/sitecore/media library/Images/Education Lab/Top Picks/2018/Ophthalmology/j732_top_pick_280x180
CME

Current Treatment Algorithms for the Management of Dry Eye Disease

This activity is supported by educational grants from Allergan, Inc. and Shire Pharmaceuticals.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.25

Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, accompanied by ocular symptoms. This CME activity will…

go to activity»